选择尺寸
关于此项目
SMILES string
O.O.[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI key
NLJMYIDDQXHKNR-UHFFFAOYSA-K
InChI
1S/C6H8O7.3Na.2H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;2*1H2/q;3*+1;;/p-3
agency
BP, JP, Ph. Eur., USP
product line
EMPROVE® API
form
solid
potency
>8000 mg/kg LD50, oral (Rat)
pH
7.5-9.0 (25 °C, 50 g/L in H2O)
mp
150 °C (anhydrous substance), >300 °C (lit.)
solubility
720 g/L
bulk density
600 kg/m3
application(s)
liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical
solid formulation
storage temp.
2-25°C
Quality Level
General description
Application
Legal Information
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
商品
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
相关内容
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持